SB
SLRN
Samsara BioCapital’s ACELYRIN SLRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,523,022
| Closed | -$6.23M | – | 38 |
|
|
2025
Q1 | $6.23M | Hold |
2,523,022
| – | – | 1.11% | 17 |
|
|
2024
Q4 | $7.92M | Hold |
2,523,022
| – | – | 1.09% | 17 |
|
|
2024
Q3 | $12.4M | Hold |
2,523,022
| – | – | 2.39% | 12 |
|
|
2024
Q2 | $11.1M | Hold |
2,523,022
| – | – | 2.33% | 13 |
|
|
2024
Q1 | $17M | Hold |
2,523,022
| – | – | 2.63% | 9 |
|
|
2023
Q4 | $18.8M | Buy |
2,523,022
+141,443
| +6% | +$1.06M | 2.93% | 9 |
|
|
2023
Q3 | $24.2M | Buy |
2,381,579
+125,557
| +6% | +$1.28M | 7.41% | 4 |
|
|
2023
Q2 | $47.2M | Buy |
+2,256,022
| New | +$47.2M | 8.28% | 3 |
|